[{"NetIncomeLoss_1_Q2_USD":-163324000.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":-4000.0,"InventoryFinishedGoods_0_Q2_USD":4477000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-16865000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":737828000.0,"Depreciation_2_Q2_USD":2747000.0,"Depreciation_1_Q2_USD":1407000.0,"ProceedsFromSaleOfShortTermInvestments_2_Q2_USD":743902000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":817996000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q2_USD":0.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":924000.0,"AssetsCurrent_0_Q2_USD":1808603000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":90252000.0,"TreasuryStockShares_0_Q2_shares":6086.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":3289000.0,"TreasuryStockValue_0_Q2_USD":924000.0,"UnrecognizedTaxBenefits_0_Q2_USD":0.0,"CommonStockSharesIssued_0_Q2_shares":94758189.0,"Assets_0_Q2_USD":1895215000.0,"ShareBasedCompensation_2_Q2_USD":17550000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":17015000.0,"CashAndDueFromBanks_0_Q2_USD":1465757000.0,"DeferredRevenue_0_Q2_USD":17632000.0,"IncreaseDecreaseInOtherCurrentLiabilities_2_Q2_USD":28077000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":54414000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":93045531.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":90723132.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":4000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":346076000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":142224000.0,"InventoryRawMaterials_0_Q2_USD":6269000.0,"InventoryWriteDown_2_Q2_USD":290000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":1179000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":7406000.0,"AccountsReceivableNetCurrent_0_Q2_USD":18029000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":null,"IncomeTaxExpenseBenefit_1_Q2_USD":null,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":930000.0,"CommonStockValue_0_Q2_USD":6000.0,"DepositsAssetsNoncurrent_0_Q2_USD":891000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":2975000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":820949000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":1323000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-1740000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-396234000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-163324000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-398575000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-168565000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":62980000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":1766573000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":11968000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":2799318000.0,"Liabilities_0_Q2_USD":223517000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShortTermInvestments_0_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":81.37,"OtherComprehensiveIncomeLossTax_2_Q2_USD":0.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":-403000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_2_Q2_USD":0.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":13099000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0_Q2_shares":7369767.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":10232000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-2341000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-5241000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-235348000.0,"InventoryWorkInProcess_0_Q2_USD":368000.0,"CostOfRevenue_2_Q2_USD":18373000.0,"CostOfRevenue_1_Q2_USD":10868000.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":-208000.0,"LiabilitiesCurrent_0_Q2_USD":193917000.0,"AccountsPayableCurrent_0_Q2_USD":125621000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":12887000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q2_USD":1028000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":3992000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":1733000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q2_USD":879000.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":300816000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":1767316000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":427000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":31642000.0,"NetIncomeLoss_2_Q2_USD":-396234000.0,"ValueAddedTaxReceivableNoncurrent_0_Q2_USD":23823000.0,"RestrictedCashNoncurrent_0_Q2_USD":743000.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_2_Q2_USD":1720000.0,"CommonStockSharesOutstanding_0_Q2_shares":94758189.0,"OtherComprehensiveIncomeLossTax_1_Q2_USD":0.0,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":57038000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":36935000.0,"OperatingIncomeLoss_2_Q2_USD":-397663000.0,"OperatingIncomeLoss_1_Q2_USD":-170571000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-396026000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-162921000.0,"InventoryNet_0_Q2_USD":11114000.0,"InvestmentIncomeInterest_2_Q2_USD":458000.0,"InvestmentIncomeInterest_1_Q2_USD":244000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1895215000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":12474000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":44741000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":6371000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-4.37,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.76,"OtherLiabilitiesCurrent_0_Q2_USD":61925000.0,"StockholdersEquity_0_Q2_USD":1671698000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":5647000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":5000.0,"LongTermInvestments_0_Q2_USD":1070000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1109837000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":1324457000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":12868000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1952000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":9610000.0,"Ticker":"ZLAB","CIK":"1704292","name":"ZAI LAB LTD","OfficialName":"Zai Lab Limited American Depositary Shares","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3400943056.0","Country":"China","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]